Header image
Moudrý Pavel Ph.D.
About me
Head of the DNA Replication Dynamics research group at the Institute of Molecular and Translational Medicine.
Researcher with extensive expertise in DNA replication and the DNA damage response.
Author of 18 scientific publications, with more than 2300 citations and an h-index of 16.
Evaluator for national and international grant competitions and research assessment.
Reviewer for international peer-reviewed scientific journals.
Supervisor and mentor of Bachelor’s, Master’s, and PhD students.
Positions are available for motivated Master’s and PhD students interested in DNA replication and clinically relevant research aimed at improving PARP inhibitor therapy. Please contact me for further information.
Journals
Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells. Journal of Proteomics. 2017, 162, 73-85, ISSN: 1874-3919, PMID: 28478306,
Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress. Oncogene. 2017, 36(17), 2405-2422, ISSN: 0950-9232, PMID: 27841863,
TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity. Journal of Cell Biology. 2016, 212(3), 281-288, ISSN: 0021-9525, PMID: 26811421,
Open positions
2 Molecular and Translational Medicine
| Project: | Cellular stress in health and disease |
|---|---|
| Supervisors: | Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D. |
| Available: | 3 |
| Intended for: | Doctoral training |
| Project: | DNA replication in human pathophysiology |
|---|---|
| Supervisors: | Moudrý Pavel Ph.D. |
| Available: | 1 |
| Intended for: | Doctoral training |
| Summary: | 1 full-time position |